| Statements |
Doctors n-90 n(%) |
Other HCWs n-107 n(%) |
P value |
|---|---|---|---|
| COVID-19 is similar to other coronaviruses in morphology and pathogenesis | 44 (45.5) | 53 (54.5) | 1.000 |
| COVID-19 virus outbreak has claimed more lives than the 2003-SARS virus outbreak. | 52 (46.4) | 60 (53.6) | 0.885 |
| COVID-19 can potentially be used as a weapon of bioterrorism. | 72 (51.4) | 68 (48.6) | 0.012 |
| Laboratory testing for COVID-19 is done only in Bio safety level-4 (BSL4) labs. | 60 (48.8) | 63 (51.2) | 0.320 |
| Vaccination against COVID-19 is available. | 12 (32.4) | 25 (67.6) | 0.099 |
| Treatment available for COVID-19 is only symptomatic | 75 (49.7) | 76 (50.3) | 0.404 |
| Acute Respiratory Distress Syndrome (ARDS) is one of the most common complications | 74 (48) | 80 (52) | 0.229 |
| Confirmed COVID-19 cases should remain in isolation for a period of 28 days or until they recover from clinical symptoms and viral detection tests are negative | 62 (43.4) | 81 (56.6) | 0.337 |
| Washing hands, social distancing and other personal hygiene methods are effective in the prevention of disease transmission. | 81 (47.6) | 89 (52.4) | 0.213 |
| Immune-compromised patients are at a higher risk of infection | 80 (48.5) | 85 (51.5) | 0.083 |
| Health care workers are at a higher risk of getting infected | 75 (48.4) | 80 (51.6) | 0.165 |